Pharmaceutical supply chain challenges have been a major cause of concern for the industry throughout the last two years. The challenges are still very much prevalent, even as the world moves ahead in the era of the new normal. This pandemic caused a major global socio-economic impact and led to disruption in almost all facets of the industry.
The 2nd Life Sciences Supply chain Resilience Forum will highlight the actual and the most common challenges faced by this industry, as well as post covid-19 impact, and the future of pharmaceutical supply chain.
The event will discuss the burning issues and risks that pharma companies are affronting, such as shortage of raw materials, technological bottlenecks, lack of integration across processes, increasing prices of drugs, and transportation obstacles. In addition, it will share the importance of flexibility and resilience and how to be prepared for any unexpected events like the ongoing pandemic. The digital transformation will take place too during the both days of the conference, where we will hear the necessity of using these new technologies and how they are shaping the whole supply chain network.